Information in this section pertains to all global PEN® partners except where country flags are
visible. Click on the flag(s) for country-specific information. If a country flag is not listed, there is
no information specific to that country.
[A] The following conclusions are supported by good evidence:
The main goal of clinical management of MetS is to reduce the risk of atherosclerotic cardiovascular disease and type 2 diabetes. The choice and intensity of treatments to reduce risk factors depend on the absolute risk of individuals. Therapeutic lifestyle change consisting of dietary modification, weight loss, physical activity and the discontinuation of smoking is the first line of treatment for MetS.
As one of the primary goals